Sponsor pipeline

Caribou Biosciences, Inc. clinical trial pipeline

Get alerts when Caribou Biosciences, Inc.'s trials change

2 active trials 1 recruiting 4 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 1
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT05722418 CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With… Relapsed/Refractory Multiple Myeloma Recruiting 2025-09-25
Not specified
NCT05332054 Long-Term Follow-up Study Lymphoma, Non-Hodgkin Enrolling by Invitation 2026-03-12

Disease areas by active trials

Multiple Myeloma (2) · Leukemia (1) · Acute Myeloid Leukemia (AML) (1) · Non-Hodgkin Lymphoma (1)

Get alerts when Caribou Biosciences, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free